AI TRiCS Named KODIT's 14th 'Innovation Icon'

AITRICS, a leader in the medical AI field, has achieved the remarkable feat of being finally selected as one of the "14th Innovation Icon" companies, a flagship scale-up program of the Korea Credit Guarantee Fund (KODIT). The 'Innovation Icon' is a core program of the Korea Credit Guarantee Fund (KODIT) that intensively supports startups aspiring to grow into global unicorn companies based on new technologies or unique business models. AITRICS successfully passed all the rigorous stages, including meticulous document review, on-site due diligence, and strict evaluation by a panel of expert judges, securing its place as one of the final five selected companies. With this selection, AITRICS will receive unprecedented credit guarantee support of up to KRW 20 billion over the next three years, along with the benefit of the lowest guarantee fee rate (0.5%). Furthermore, it will not only receive additional guarantee fee support through partner banks but also comprehensive non-financial services for sustainable growth, including overseas expansion, consulting, and public relations, thereby laying the groundwork for remarkable advancement. The key factor in AITRICS' selection as an Innovation Icon lies in its execution capability, having successfully demonstrated medical AI that can be practically utilized in clinical settings. Securing clinical evidence through a solid foundation of cooperation with major domestic medical institutions and simultaneously proving its technological prowess and growth potential through active expansion of global partnerships garnered high evaluations from the judging panel. Through this opportunity, the company has firmly secured financial stability for the execution of its mid-to-long-term growth strategies. Based on this, it has gained a powerful growth engine to pursue technology advancement and domestic and international business expansion strategies even more stably and aggressively. Choi Cheol-jin, Chief Financial Officer (CFO) of AITRICS, stated, "This selection as an Innovation Icon is a highly significant outcome, officially recognizing AITRICS' technological growth potential and sustainability." He further expressed his ambition, "Leveraging the secured financial and non-financial support, we will accelerate technology development to maximize actual utilization value in clinical settings and further expand cooperation with global partners."